相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Ruvim Izikson et al.
LANCET RESPIRATORY MEDICINE (2022)
Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes
Kevin W. McConeghy et al.
CLINICAL INFECTIOUS DISEASES (2021)
Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network
Jill M. Ferdinands et al.
CLINICAL INFECTIOUS DISEASES (2021)
Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season
Hector S. Izurieta et al.
CLINICAL INFECTIOUS DISEASES (2021)
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease A Randomized Clinical Trial
Orly Vardeny et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults A Randomized Clinical Trial
Kenneth E. Schmader et al.
JAMA NETWORK OPEN (2021)
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system
Emily Jane Woo et al.
VACCINE (2021)
Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season
Ainara Mira-Iglesias et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season
Stephen Pelton et al.
VACCINE (2021)
Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults
Jill M. Ferdinands et al.
CLINICAL INFECTIOUS DISEASES (2020)
Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study
Robertus van Aalst et al.
VACCINE (2020)
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019
Hector S. Izurieta et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations
Emmanuel B. Walter et al.
PEDIATRICS (2020)
High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15
Yinong Young-Xu et al.
EUROSURVEILLANCE (2020)
Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season
Stephen Pelton et al.
VACCINES (2020)
Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness
B. E. Young et al.
EPIDEMIOLOGY AND INFECTION (2020)
Influenza Vaccine Effectiveness Among Children for the 2017-2018 Season
Lauren N. Powell et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Intraseason Waning of Influenza Vaccine Effectiveness
G. Thomas Ray et al.
CLINICAL INFECTIOUS DISEASES (2019)
The impact of influenza infection on young children, their family and the health care system
Gabriela A. Willis et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2019)
Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season
Melissa A. Rolfes et al.
CLINICAL INFECTIOUS DISEASES (2019)
Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method
Yinong Young-Xu et al.
VACCINE (2019)
Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years
Yun Lu et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017
Yixiang Ng et al.
VACCINE (2019)
Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15
James G. Donahue et al.
VACCINE (2019)
Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018
Hector S. Izurieta et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis
Brenda L. Coleman et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies
Barnaby Young et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Effects of seasonal and pandemic influenza on health-related quality of life, work and school absence in England: Results from the Flu Watch cohort study
Ellen B. Fragaszy et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness
Melissa A. Rolfes et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients
Yinong Young-Xu et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
被撤回的出版物: Influenza Vaccination During Pregnancy (Retracted article. See vol. 131, pg. 751, 2018)
Neil S. Silverman et al.
OBSTETRICS AND GYNECOLOGY (2018)
Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine
Myron J. Levin et al.
VACCINE (2018)
Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial
Kei Nakashima et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Seasonal influenza vaccine in immunocompromised persons
Mohammad Bosaeed et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
Tino F. Schwarz et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014
David K. Shay et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Influenza and Workplace Productivity Loss in Working Adults
Jeffrey J. Van Wormer et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2017)
Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial
Mark C. Steinhoff et al.
LANCET INFECTIOUS DISEASES (2017)
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Lisa M. Dunkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
Emily Jane Woo et al.
VACCINE (2017)
Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
J. Puig-Barbera et al.
VACCINE (2017)
Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12
James G. Donahue et al.
VACCINE (2017)
Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial
Stefan Gravenstein et al.
LANCET RESPIRATORY MEDICINE (2017)
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection
R G Pebody et al.
Eurosurveillance (2017)
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study
E Kissling et al.
Eurosurveillance (2017)
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12
J Castilla et al.
Eurosurveillance (2017)
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
E. Kissling et al.
EUROSURVEILLANCE (2016)
Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
Milagritos D. Tapia et al.
LANCET INFECTIOUS DISEASES (2016)
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months
Jonathan Duffy et al.
PEDIATRICS (2016)
Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons
Rongxia Li et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS
Christina D. Chambers et al.
VACCINE (2016)
Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014
Jennifer M. Radin et al.
VACCINE (2016)
Influenza Outbreaks Among Passengers and Crew on Two Cruise Ships: A Recent Account of Preparedness and Response to an Ever-Present Challenge
Alexander J. Millman et al.
JOURNAL OF TRAVEL MEDICINE (2015)
Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis
Hector S. Izurieta et al.
LANCET INFECTIOUS DISEASES (2015)
Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy
Lakshmi Sukumaran et al.
OBSTETRICS AND GYNECOLOGY (2015)
Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season
Edward A. Belongia et al.
VACCINE (2015)
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines
Carlos A. DiazGranados et al.
VACCINE (2015)
Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults
Joon Young Song et al.
VACCINE (2015)
Influenza vaccination during pregnancy: A systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes
M. McMillan et al.
VACCINE (2015)
Allergic Reactions After Egg-Free Recombinant Influenza Vaccine: Reports to the US Vaccine Adverse Event Reporting System
Emily Jane Woo
CLINICAL INFECTIOUS DISEASES (2015)
Maternal Influenza Immunization and Birth Outcomes of Stillbirth and Spontaneous Abortion: A Systematic Review and Meta-analysis
Kristin N. Bratton et al.
CLINICAL INFECTIOUS DISEASES (2015)
Prospective Cohort Study of the Safety of an Influenza A(H1N1) Vaccine in Pregnant Chinese Women
Fubao Ma et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Influenza Vaccination of Pregnant Women and Protection of Their Infants
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: A population-based study in Taiwan
Wan-Ting Huang et al.
VACCINE (2014)
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
Sharon E. Frey et al.
VACCINE (2014)
Risk of Fever After Pediatric Trivalent Inactivated Influenza Vaccine and 13-Valent Pneumococcal Conjugate Vaccine
Melissa S. Stockwell et al.
JAMA PEDIATRICS (2014)
Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia
Irani Ratnam et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion
Stephanie A. Irving et al.
OBSTETRICS AND GYNECOLOGY (2013)
The Burden of Influenza in Young Children, 2004-2009
Katherine A. Poehling et al.
PEDIATRICS (2013)
Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants
Christina D. Chambers et al.
VACCINE (2013)
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
Terho Heikkinen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults
Robert W. Frenck et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Evaluating the Hazard of Foetal Death following H1N1 Influenza Vaccination; A Population Based Cohort Study in the UK GPRD
Cormac J. Sammon et al.
PLOS ONE (2012)
A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy
Marc Oppermann et al.
VACCINE (2012)
Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark
Bjorn Pasternak et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants
Angelia A. Eick et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2011)
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
T. F. Schwarz et al.
VACCINE (2011)
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Alicia M. Siston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
Lucy Chai See Lum et al.
VACCINE (2010)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old
W. A. Keitel et al.
VACCINE (2009)
Effectiveness of maternal influenza immunization in mothers and infants
K. Zaman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age
Terry Nolan et al.
PEDIATRICS (2008)
Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003-2004 and 2004-2005 Influenza Seasons
Katherine W. Eisenberg et al.
PEDIATRICS (2008)
Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older
Boris Kerzner et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults
Shelly A. McNeil et al.
VACCINE (2007)
Influenza- and RSV-associated hospitalizations among adults
John P. Mullooly et al.
VACCINE (2007)
Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Mandy A. Allison et al.
JOURNAL OF PEDIATRICS (2006)
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children
Kathleen M. Neuzil et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The underrecognized burden of influenza in young children
Katherine A. Poehling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses
DP Ritzwoller et al.
PEDIATRICS (2005)
Influenza virus infection in travelers to tropical and subtropical countries
M Mutsch et al.
CLINICAL INFECTIOUS DISEASES (2005)
Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory
TM Uyeki et al.
CLINICAL INFECTIOUS DISEASES (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
